These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 39305562)

  • 21. Efficacy of Ruxolitinib with corticosteroids in idiopathic pneumonia syndrome post-allogeneic hematopoietic stem cell transplantation: A single-center experience and systematic review.
    Shahzad M; Khan MA; Amin MK; Sarfraz Z; Zulfiqar F; Qasim H; Bansal R; Brownback K; Ahmed N; Abhyankar SH; McGuirk JP; Singh AK; Mushtaq MU
    Transpl Immunol; 2024 Dec; 87():102135. PubMed ID: 39368752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT.
    Crawley E; Anderson E; Cochrane M; Shirkey BA; Parslow R; Hollingworth W; Mills N; Gaunt D; Treneman-Evans G; Rai M; Macleod J; Kessler D; Pitts K; Cooper S; Loades M; Annaw A; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Metcalfe C
    Health Technol Assess; 2024 Oct; 28(70):1-134. PubMed ID: 39485730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors.
    Pinto N; Albert CM; Taylor MR; Ullom HB; Wilson AL; Huang W; Wendler J; Pattabhi S; Seidel K; Brown C; Gustafson JA; Rawlings-Rhea SD; Cheeney SHE; Burleigh K; Gustafson HH; Orentas RJ; Vitanza NA; Gardner RA; Jensen MC; Park JR
    J Clin Oncol; 2024 Dec; 42(35):4163-4172. PubMed ID: 39255444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab for maintenance of medically-induced remission in Crohn's disease.
    Gordon M; Sinopoulou V; Akobeng AK; Sarian A; Moran GW
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD012609. PubMed ID: 38372447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without Radiation.
    Dimitrov M; Merkle S; Cao Q; Tryon RK; Vercellotti GM; Holtan SG; Kao RL; Srikanthan M; Terezakis SA; Tolar J; Ebens CL
    Transplant Cell Ther; 2024 Oct; 30(10):1005.e1-1005.e17. PubMed ID: 39002862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes with chimeric antigen receptor T-cell therapy in Rheumatological disorders: A systematic review.
    Zulfiqar F; Shahzad M; Amin MK; Vyas A; Sarfraz Z; Zainab A; Qasim H; Kaur D; Khavandgar N; Lutfi F; Hematti P; McGuirk JP; Mushtaq MU
    Transpl Immunol; 2024 Dec; 87():102137. PubMed ID: 39442586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
    Kiene S; Albrecht M; Theurich S; Scheid C; Skoetz N; Holtick U
    Cochrane Database Syst Rev; 2024 Nov; 11(11):CD010189. PubMed ID: 39508306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Construction of CD138-targeted chimeric antigen receptor- modified T cells and their effect in multiple myeloma therapy].
    Guo CC; Lu Y; Tang KJ; Xing HY; Tian Z; Rao Q; Wang M; Xiong DS; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):436-444. PubMed ID: 38964917
    [No Abstract]   [Full Text] [Related]  

  • 29. BCMA-BBZ-OX40 CAR-T Therapy Using an Instant Manufacturing Platform in Multiple Myeloma.
    Wang T; Yang Y; Ma L; Feng R; Li J; Zhang C; Bai J; Ding Y; Liu G; Wu F; Lu X; Feng S; Li Z; He T; Li J; Liu H
    J Immunother Cancer; 2024 Sep; 12(9):. PubMed ID: 39313307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes as a risk factor for tuberculosis disease.
    Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD016013. PubMed ID: 39177079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamoxifen for adults with hepatocellular carcinoma.
    Naing C; Ni H; Aung HH
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapy.
    Mao D; Reiner AS; Chen X; Park J; Pennisi M; Perales MA; Avila EK; Santomasso BD
    Sci Rep; 2024 Nov; 14(1):29090. PubMed ID: 39580601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of the therapeutic effect of avatinib bridged allogeneic hematopoietic stem cell transplantation on 7 cases of recurrent/refractory RUNX1-RUNX1T1 positive acute myeloid leukemia with KIT mutations].
    Han SY; Zhou HX; Han Y; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2024 Aug; 45(8):767-771. PubMed ID: 39307724
    [No Abstract]   [Full Text] [Related]  

  • 34. Addition of Nivolumab Tailored by Expansion of CAR-T Cells in Patients with Stable/Progressive Large B Cell Lymphoma at Lymphodepletion-A Phase 2, Prospective Interventional Study.
    Ram R; Amit O; Perry C; Herishanu Y; Avivi I; Sarid N; Apel A; Preis M; Aviv A; Shapira S; Shragai T; Joffe E; Shargian L; Herzog-Tsarfati K; Eylati N; Acria L; Fridberg G; Gold R; Glait-Santar C; Kay S; Gal-Rabinovich K; Rosenberg D; Setter-Marco N; Beyar-Katz O
    Transplant Cell Ther; 2024 Dec; 30(12):1178-1188. PubMed ID: 39396632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS.
    Radford M; Garcia-Horton A; Badami R; Jin E; Usmani N; Grafodatskaya D; McCready E; Khalaf D; Walker I; Leber B; Lepic K; Pond G; Berg T
    Transplant Cell Ther; 2024 Nov; ():. PubMed ID: 39547311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of the Wound Healing Questionnaire in the diagnosis of surgical-site infection after abdominal surgery in low- and middle-income countries.
    NIHR Global Health Research Unit on Global Surgery
    Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38747515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021.
    Gentzke AS; Wang TW; Cornelius M; Park-Lee E; Ren C; Sawdey MD; Cullen KA; Loretan C; Jamal A; Homa DM
    MMWR Surveill Summ; 2022 Mar; 71(5):1-29. PubMed ID: 35271557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. REGAL: galinpepimut-S vs. best available therapy as maintenance therapy for acute myeloid leukemia in second remission.
    Jamy O; Cicic D
    Future Oncol; 2024 Nov; ():1-9. PubMed ID: 39606837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic stem cell transplantation to improve prognosis in aggressive monomorphic epitheliotropic intestinal T-cell lymphoma.
    Min GJ; Oh YE; Jeon Y; Kim TY; Kim BS; Kwag D; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Cho SG
    Front Oncol; 2024; 14():1388623. PubMed ID: 39640274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial.
    Kim P; Sanchez AM; Penke TJR; Tuson HH; Kime JC; McKee RW; Slone WL; Conley NR; McMillan LJ; Prybol CJ; Garofolo PM
    Lancet Infect Dis; 2024 Dec; 24(12):1319-1332. PubMed ID: 39134085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.